You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-CTLA-4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)

Recruiting
  • NSCLC (Non-small-cell Lung Cancer)
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Sep 21, 2022

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
  • Graft Rejection
  • +3 more
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
Jun 21, 2023

Recurrent or Metastatic Cervical Cancer Trial in Changsha, Hangzhou (AK104, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Recurrent or Metastatic Cervical Cancer
  • AK104
  • +3 more
  • Changsha, Hunan, China
  • +1 more
Mar 28, 2022

Solid Tumor, Adult Trial in Australia, Hong Kong (CS1002, CS1003)

Completed
  • Solid Tumor, Adult
  • Albury, New South Wales, Australia
  • +9 more
Dec 15, 2022

Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)

Active, not recruiting
  • Head and Neck Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 30, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Esophageal Squamous Cell Carcinoma Trial (QL1706)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 4, 2022

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Synovial Sarcoma Trial in New York (ipilimumab)

Terminated
Has Results
  • Synovial Sarcoma
  • ipilimumab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 23, 2021

Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

Not yet recruiting
  • Locally Advanced Thyroid Gland Anaplastic Carcinoma
  • +2 more
  • Chicago, Illinois
  • +1 more
Jul 7, 2022

Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)

Active, not recruiting
  • Advanced Solid Tumours
  • +4 more
  • Durvalumab + Tremelimumab + metronomic Vinorelbine
  • Angers, France
  • +8 more
Jun 1, 2022

Hepatocellular Carcinoma Trial in Beijing (AK104, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 17, 2022

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Hepatocellular Carcinoma Trial in Hangzhou (AK104 lenvatinib, AK104)

Active, not recruiting
  • Hepatocellular Carcinoma
  • AK104 lenvatinib
  • AK104
  • Hangzhou, Zhejiang, China
    The first affilited hospital zhejiang university school of medci
Oct 17, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 8, 2023

Advanced Solid Tumor Trial in Zhengzhou, Linyi (BAT4706 Injection, BAT1308 Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • BAT4706 Injection
  • BAT1308 Injection
  • Zhengzhou, Henan, China
  • +2 more
Nov 14, 2023

Cancer Trial in Saint Louis, Houston (Vopratelimab, Ipilimumab, Nivolumab)

Active, not recruiting
  • Cancer
  • Saint Louis, Missouri
  • +2 more
Sep 9, 2022

Prostate Cancer Trial in New York (BMS-986218 and Degarelix, Degarelix)

Recruiting
  • Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2021

Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • ONC-392
  • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
  • (no location specified)
Dec 27, 2022